Recent technological advances have shed unexpected light on the CD8+ T cell responses to pathogens and have raised concerns that a familiar quantitative assay is wrong. The most exciting of the new advances is the MHC tetramer. Ever since T cells were first identified, there have been attempts to
No takes yet. Share an insight, caveat, or question.
McMichael et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: